![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » EU Industry Calls for More Dialogue on Proposed Pharmacovigilance Fees
EU Industry Calls for More Dialogue on Proposed Pharmacovigilance Fees
While manufacturers support a strong pharmacovigilance system to ensure patient safety, the proposed costs are a source of concern, “especially in light of the annual saving for the pharmaceutical industry of 145 million euros (US $201 million) that was anticipated in the 2008 European Commission ‘impact assessment,’” a coalition of five trade groups says.
International Pharmaceutical Regulatory Monitor
Drugs Postmarket Safety Quality Regulatory AffairsInternational Pharmaceutical Regulatory Monitor
Upcoming Events
-
21Oct